Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+50Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Pancreatic Neoplasm+16.7Malignant Vulvar Neoplasm+13.4Malignant Esophageal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Testicular Neoplasm+3.3Malignant Vaginal Neoplasm+3.3Malignant Kidney Neoplasm+3.3Malignant Mesothelioma+3.3Malignant Anal Neoplasm0Malignant Liver Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+50100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41883
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
90
activityPercentile
40

ranking row 2601544

2=Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16646
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2601545

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8188
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2601546

4=Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3866
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2601548

4=Malignant Pancreatic Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42757
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
96.7
activityPercentile
80

ranking row 2601547

6=Malignant Vulvar Neoplasm+13.483.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1221
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
26.7
activityPercentile
13.3

ranking row 2601549

7=Malignant Esophageal Neoplasm+3.480Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
15459
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2601550

8=Malignant Salivary Gland Neoplasm+3.376.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1027
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2601551

9=Malignant Testicular Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
431
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
10
activityPercentile
6.7

ranking row 2601552

9=Malignant Vaginal Neoplasm+3.373.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
386
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
3.3
activityPercentile
0

ranking row 2601553

11=Malignant Kidney Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13842
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56.7

ranking row 2601555

11=Malignant Mesothelioma+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2508
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
33.3
activityPercentile
30

ranking row 2601554

13=Malignant Anal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1130
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
23.3
activityPercentile
23.3

ranking row 2601559

13=Malignant Liver Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
26569
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2601557

13=Malignant Lung Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
148869
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2601556

13=Malignant Prostate Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30370
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2601558

13=Malignant Rectal Neoplasm060Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10403
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
50
activityPercentile
50

ranking row 2601560

18=Malignant Thyroid Gland Neoplasm-3.343.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2042
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
30
activityPercentile
33.3

ranking row 2601561

19=Malignant Hypopharyngeal Neoplasm-3.340Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
403
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2601562

20=Malignant Breast Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
41951
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2601563

20=Malignant Central Nervous System Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16834
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2601564

22=Malignant Penile Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
317
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2601565

23=Malignant Ovarian Neoplasm-6.726.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14223
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
63.3
activityPercentile
70

ranking row 2601566

24=Leukemia-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23287
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2601567

24=Malignant Uterine Corpus Neoplasm-1023.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5410
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2601568

26=Malignant Gastric Neoplasm-13.416.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11433
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
53.3
activityPercentile
66.7

ranking row 2601569

27=Multiple Myeloma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12266
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
56.7
activityPercentile
73.3

ranking row 2601570

27=Non-Hodgkin Lymphoma-16.613.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
20268
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2601571

29=Malignant Cervical Neoplasm-206.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4188
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2601572

30=Hodgkin Lymphoma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1000
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
16.7
activityPercentile
36.7

ranking row 2601573

31=Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
726
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2601574

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 2569d18c273061132d74c960